Evidence map›Paper›PMID 33050387›Full record

ArticleMicroorganisms2020

Nasmille L Larke-Mejía, Ornella Carrión, Andrew T Crombie, Terry J McGenity, J Colin Murrell

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Analysis of Essential Isoprene Metabolic Pathway Proteins inApplied and environmental microbiology · 2023
    Article
  7. Article
  8. Article
  9. Characterization of the GlutathioneMicrobiology spectrum · 2021
    Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Nasmille L Larke-MejíaSchool of Environmental Sciences, University of East Anglia, Norwich NR4 7TJ, UK.
Ornella CarriónSchool of Environmental Sciences, University of East Anglia, Norwich NR4 7TJ, UK.
Andrew T CrombieSchool of Biological Sciences, University of East Anglia, Norwich NR4 7TJ, UK.
Terry J McGenitySchool of Life Sciences, University of Essex, Colchester CO4 3SQ, UK.
J Colin MurrellSchool of Environmental Sciences, University of East Anglia, Norwich NR4 7TJ, UK.
University of East Anglia · GBUniversity of Essex · GB

Funding

Departamento Administrativo de Ciencia, Tecnología e Innovación (COLCIENCIAS) 646 de 2014European Research Council 694578Leverhulme Early Career Fellowship ECF-2016-626Natural Environment Research Council NE/J009555/1Natural Environment Research Council NE/J009725/1
6 · The paper itself

Abstract

The volatile secondary metabolite, isoprene, is released by trees to the atmosphere in enormous quantities, where it has important effects on air quality and climate. Oil palm trees, one of the highest isoprene emitters, are increasingly dominating agroforestry over large areas of Asia, with associated uncertainties over their effects on climate. Microbes capable of using isoprene as a source of carbon for growth have been identified in soils and in the tree phyllosphere, and most are members of the Actinobacteria. Here, we used DNA stable isotope probing to identify the isoprene-degrading bacteria associated with oil palm leaves and inhabiting the surrounding soil. Among the most abundant isoprene degraders of the leaf-associated community were members of the Sphingomonadales, although no representatives of this order were previously known to degrade isoprene. Informed by these data, we obtained representatives of the most abundant isoprene degraders in enrichments, including

Indexed as

DNA-SIPisoAisoprene degradationisoprene monooxygenaseSphingopyxistargeted isolation

Identifiers

PMID33050387
PMCPMC7600658
OpenAlexW3092038491

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.